Literature DB >> 11152506

Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.

R Patzwahl1, V Meier, G Ramadori, S Mihm.   

Abstract

Hepatitis C virus (HCV) infection causes acute and often also chronic liver disease. Worldwide, prevalence of infection is estimated to exceed that of human immunodeficiency virus infection fourfold. Because of the lack of appropriate animal models, knowledge of interactions between virus and host is still limited. Assumptions regarding pathogenesis or the activation status of innate antiviral host responses, for instance, derive mainly from clinical observations and from expression analyses of selected genes. To obtain a more objective insight into virus-host interrelationships, we used suppression-subtractive hybridization to compare gene expression in HCV-infected and non-HCV-infected liver tissues samples. Four differentially expressed genes were found: (i) the gamma interferon (IFN-gamma)-inducible chemokine IP-10 gene; (ii) the IFN-alpha/beta-inducible antiviral MxA gene; (iii) the gene encoding IFN-alpha/beta-inducible p44, shown to be associated with ultrastructural cytoplasmic entities within hepatocytes of non-A, non-B hepatitis-infected chimpanzees; and (iv) the gene encoding IFN-alpha/beta/gamma-inducible IFI-56K, a protein recently shown to interact with the eukaryotic translation initiation factor eIF-3. Compared to hepatic gene expression in patients with liver diseases unrelated to viral infections, expression in patients with chronic HCV infection was up to 50-fold higher. While in patients with chronic HBV infection IP-10 was slightly activated as well, the IFN-alpha/beta-regulated genes were not. Revealing a dominance of hepatic interferon-regulated processes in chronic HCV infection, data on the enhanced expression of the IFN-gamma regulated IP-10 support earlier findings and may explain the composition of the hepatic cellular infiltrate. The data on enhanced expression of IFN-alpha/beta inducible genes might be germane to therapeutic considerations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152506      PMCID: PMC114039          DOI: 10.1128/JVI.75.3.1332-1338.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

Authors:  S Nakajima-Iijima; H Hamada; P Reddy; T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus.

Authors:  J Guo; G C Sen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Molecular cloning, full-length sequence and preliminary characterization of a 56-kDa protein induced by human interferons.

Authors:  M Wathelet; S Moutschen; P Defilippi; A Cravador; M Collet; G Huez; J Content
Journal:  Eur J Biochem       Date:  1986-02-17

5.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

6.  Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees.

Authors:  U Pfeifer; R Thomssen; K Legler; U Böttcher; W Gerlich; E Weinmann; O Klinge
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1980

7.  Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA.

Authors:  J Chebath; G Merlin; R Metz; P Benech; M Revel
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.

Authors:  V Meier; S Mihm; G Ramadori
Journal:  J Med Virol       Date:  2000-11       Impact factor: 2.327

9.  Production of antibody associated with non-A, non-B hepatitis in a chimpanzee lymphoblastoid cell line established by in vitro transformation with Epstein-Barr virus.

Authors:  Y K Shimizu; M Oomura; K Abe; M Uno; E Yamada; Y Ono; T Shikata
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Nucleotide sequence and the encoded amino acids of human serum albumin mRNA.

Authors:  A Dugaiczyk; S W Law; O E Dennison
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

View more
  28 in total

1.  Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.

Authors:  M Diago; G Castellano; J García-Samaniego; C Pérez; I Fernández; M Romero; O L Iacono; C García-Monzón
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

Review 2.  Cytokines and HCV-related autoimmune disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Ilaria Ruffilli; Poupak Fallahi
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Danoprevir monotherapy decreases inflammatory markers in patients with chronic hepatitis C virus infection.

Authors:  Caralee J Schaefer; Karl Kossen; Sharlene R Lim; Jiing-Huey Lin; Lin Pan; Williamson Bradford; Patrick F Smith; Scott D Seiwert
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

Review 5.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

6.  Survey of transcript expression in rainbow trout leukocytes reveals a major contribution of interferon-responsive genes in the early response to a rhabdovirus infection.

Authors:  Caroline O'Farrell; Nikta Vaghefi; Monique Cantonnet; Bénédicte Buteau; Pierre Boudinot; Abdenour Benmansour
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

Review 8.  Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.

Authors:  Juan R Larrubia; Selma Benito-Martínez; Miryam Calvino; Eduardo Sanz-de-Villalobos; Trinidad Parra-Cid
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

9.  Host factors associated with serologic inflammatory markers assessed using multiplex assays.

Authors:  Heather S McKay; Jay H Bream; Joseph B Margolick; Otoniel Martínez-Maza; John P Phair; Charles R Rinaldo; Alison G Abraham; Lisa P Jacobson
Journal:  Cytokine       Date:  2016-06-10       Impact factor: 3.861

10.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.